To anyone griping or acting skeptical about FX-322 treating tinnitus in a positive way... Frequency Therapeutics has gotten so loose about the fact that they've received first-hand testimonials about tinnitus improving for patients that got 1 dose in the Phase 1/2.
1. They can't keep repeating this as a publicly-traded company if it is a lie. Lawsuits would ensue.
2. The patients involved in the Phase 1/2 and Long-term study are probably still under a confidentiality agreement.
3. The patients may not want their identity revealed. IMAGINE the crash of tinnitus sufferers exploding your every inbox.
4. It's in the Phase 2A. The TFI is there for a reason.
FINALLY, have you all not listed to the very podcast produced by this forum? It's been about a month since I quoted this... but Carl LeBel said it here first... FX-322 seems to help tinnitus... on a
tinnitus podcast:
From
Episode 12: Hearing Lost and Found — Frequency Therapeutics:
"... there is anecdotal reports as patients have come back and visited with ENTs when they have had conversations with them about how they are doing. Some of them have offered that they have had improvements in tinnitus, there's nothing that we can quantitate there. Again, it adds to the excitement of the opportunity. "
- Carl LeBel, Frequency Therapeutics
FX-322 works as intended. It clearly treats noise-induced / sensorineural hearing loss related tinnitus. We will know to what extent when the Phase 2A ends. I hope it's a lot, so this debate is put to rest.
FINALLY: Frequency's willingness to be transparent (good, neutral, bad) on the data they continue to provide on a regular basis re: trials, treatments, progress is a good sign this company has a legitimate product. I have yet to see them dodge questions, omit data, do any type of reversal on anything. This should give a lot of investors and potential patients of this drug a lot of confidence.
*MIC DROP*